Clinical trial
Eniluracil and Surgery in Treating Patients With Primary or Metastatic…
NCT00004195 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00004195 |
|---|---|
| Title | Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer |
| Official title | Evaluation of Dihydropyrimidine Dehydrogenase (DPD) Activity in Surgically Resected Primary and Metastatic Colorectal Cancer After 48 hr Pretreatment With Eniluracil |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH Glaxo Wellcome Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | eniluracil, conventional colon surgery |
| Enrollment | 28 |
| Start date | Sep 1, 1998 |
| Primary completion | Oct 1, 1999 |
| Completion | May 1, 2001 |
| First posted | Sep 16, 2004 |
| Last update posted | Jun 15, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: